Angel News

Angel News

Back to Homepage

5th July 2018

NVM leads investment in Newcells Biotech

NVM Private Equity has invested £1.5 million of growth capital into Newcastle based hiPSC company Newcells Biotech alongside existing investors Northstar Ventures, who have provided a further £500k bringing the total round to £2 million.

Founded in 2015 and headquartered at the world-renowned International Centre for Life in Newcastle (an incubator space for young and established biotechnology companies) Newcells is a successful, early-stage, life-sciences spinout from Newcastle University, which is leading the way in the development of Human Induced Pluripotent Stem Cells (hiPSCs) for efficacy and toxicity testing in the drug development sector.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage